Prelude Therapeutics Inc (PRLD)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.02 | -0.520833333333 | 3.84 | 3.95 | 3.6 | 54447 | 3.81420634 | CS |
| 4 | -0.23 | -5.67901234568 | 4.05 | 4.44 | 3.32 | 50285 | 3.79574536 | CS |
| 12 | -0.94 | -19.7478991597 | 4.76 | 5.83 | 3.32 | 43430 | 4.07929176 | CS |
| 26 | -0.14 | -3.53535353535 | 3.96 | 5.83 | 2.62 | 59077 | 3.95245519 | CS |
| 52 | -1.45 | -27.5142314991 | 5.27 | 5.83 | 1.66 | 115397 | 3.46756983 | CS |
| 156 | -27.36 | -87.7485567672 | 31.18 | 43.5499 | 1.66 | 180327 | 12.11632437 | CS |
| 260 | -21.94 | -85.1708074534 | 25.76 | 95.375 | 1.66 | 186387 | 20.58452404 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
